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Abstract 
Road construction workers are simultaneously exposed to two carcinogens; solar ultraviolet (UV-S) radiation and 
polycyclic aromatic hydrocarbons (PAHs) in bitumen emissions. The combined exposure may lead to 
photogenotoxicity and enhanced PAH skin permeation rates. Skin permeation rates (J) for selected PAHs in a 
mixture (PAH-mix) or in bitumen fume condensate (BFC) with and without UV-S co-exposures were measured with 
in vitro flow-through diffusion cells mounted with human viable skin and results compared. Possible biomarkers 
were explored. Js were greater with UV-S for naphthalene, anthracene, and pyrene in BFC (0.08-
0.1ng/cm2/h) compared to without (0.02-0.26ng/cm2/h). This was true for anthracene, pyrene, and chrysene in the 
PAH-mix. Naphthalene and benzo(a)pyrene (BaP) in the PAH-mix had greater Js without (0.97-
13.01ng/cm2/h) compared to with UV-S (0.40-6.35ng/cm2/h). Time until permeation (Tlags ) in the PAH-mix were 
generally shorter compared to the BFC, and they ranged from 1 to 13h. The vehicle matrix could potentially be the 
reason for this discrepancy as BFC contains additional not identified substances. Qualitative interpretation of p53 
suggested a dose-response with UV-S, and somewhat with the co-exposures. MMP1, p65 and cKIT were not 
exploitable. Although not statistically different, PAHs permeate human viable skin faster with simultaneous 
exposures to UV.  
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Introduction 
Simultaneous exposures to two carcinogens; polycyclic aromatic hydrocarbons (PAHs) and solar ultraviolet 
radiation (UV-S) are common among road pavers; a world-wide activity involving tens of thousands of workers 
(IARC 2013). Pavers work outside (UV-S exposures) handling hot straight-run bitumen containing PAHs. The 
International Agency for Research on Cancer (IARC) concluded in 2013 that occupational exposures to paving 
bitumen (CAS no. 8052-42-4) and their emissions during road paving are possibly carcinogenic to humans (Group 
2B) (IARC 2013).  
Road paving workers are not only exposed via inhalation, but to a large extent via skin which in combination with 
UV-S exposures can increase the risk of skin cancer (Burke and Wei 2009). The synergistic mechanism for this is 
not known. The extent of skin exposures to bitumen (or asphalt) among road paving workers depends on the tasks 
performed; pavers – drive the paver machine distributing the asphalt (bitumen and gravel mix), screed operators – 
controls the even spread of asphalt behind the paving machine, rakers – move the excess bitumen to fill in voids and 
prepare joints for rolling, and rollers – drive the machinery that compacts the asphalt mat. The surface contamination 
of the tools will also add to the overall skin exposures.  
The PAH concentrations in bitumen fume increase with the temperature (Boilliet et al. 2015; Cavallari et al. 2012; 
Lange et al. 2007). To reduce the amount of PAHs in bitumen, the paving material is generally heated to only 180ºC. 
Bitumen fume condensates (BFCs) have been analyzed for PAH content, and typical PAHs found were (listed by 
name and IARC category): naphthalene (cat. 2B), acenaphthyene (cat. not assessed), acenaphthene (cat. 3), 
phenanthrene (cat. 3), anthracene (cat. 3), fluoranthene (cat. 3), pyrene (cat. 3), benzo[a]anthracene (cat. 2B), 
chrysene (cat. 2B), and benzo[a]pyrene (BaP) (cat.1) (reviewed in (Binet et al. 2002)).    
Sunlight (UV-S) is a carcinogen and the main cause of skin cancer development (IARC 1992; Rass and Reichrath 
2008). The solar radiation is composed of 91% visible (400-700 nm), 8.7% UVA (320-400 nm), and 0.3% UVB 
(280-320 nm). It is known that UVA acts on endogenous photosensitizers to form free radicals, which subsequently 
damage DNA, cell membranes, and other cellular constituents (Burke and Wei 2009). UVB induces 
immunosuppression while UVA does not. UVA penetrates the full epidermis and dermis and decreases the skin’s 
protective immune response, thereby decreasing natural recognition and elimination of cells genetically damaged by 
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UVB (Garssen and van Loveren 2001). Quantities of UV radiation are expressed using radiometric terminology, and 
measured in clinical terms as the standard erythemal dose (SED); a measure of the erythemal effectiveness of UV 
exposure. UVA is less erythrogenic and carcinogenic than UVB. It is not known what UVA and UVB doses cause 
cancers. 
PAHs are photosensitzers and absorb sunlight in the UVA range thereby becoming excited to upper energy states 
(reviewed in (Yu 2002)). These can undergo electron or energy transfers to molecular oxygen, solvents, or 
biological molecules in the cell and generate reactive oxygen species (ROS). A ROS pathway has been proposed 
(Burke and Wei 2009) as a likely cancer mechanism. It is generally recognized that oxidative stress is associated 
with p53-dependent cell cycle arrest. The p53 gene can also be induced by BaP diol epoxide; the BaP metabolite 
recognized as the ultimate carcinogen, in human epithelial cells (Perlow et al. 2002). Another, not yet tested 
hypothesis is that PAHs are absorbed through skin at a greater extent because UV-S exposures break down the 
skin’s structure (Lahmann et al. 2001; Scharffetter et al. 1991) leading to a more permeable skin barrier. For 
instance, skin penetration enhancement after solar irradiation has been observed in assays with caffeine (Gelis et al. 
2002).  
Even at PAH concentrations below the toxic or tumorigenic levels, the combined impact of the two factors; UV-S 
and PAHs, may contribute to an increased tumorigenicity in animals (Liu et al. 1998; Saladi et al. 2003; Shyong et 
al. 2003; Wang, Saladi, and Wei 2003). Exposure to BaP and UVA synergistically induced oxidative DNA damage 
(Liu et al. 1998; Saladi et al. 2003; Shyong et al. 2003). This can enhance the mutational potential of genes such as 
ras and p53; genes that activate signal transduction pathways and protective enzymes (Saladi et al. 2003). From this 
activation, p53 would be expected to be upregulated. UVB can also increase the keratinocytes’ production stem cell 
factor (SCF). SCFs bind to the tyrosine-protein kinase (cKIT) on the melanocytes and result in receptor dimerization 
and activation of protein kinase activity (Roskoski 2005; Yoshida et al. 2001). An increase in SCF would induce the 
production of cKIT receptors. UVB can also induce the regulation of cell survival and proliferation in 
melanogenesis directly by increasing cKIT receptors (Hachiya et al. 2001). As a result, cKIT would be expected to 
be upregulated. ΔNP63α (the p63 isoform lacking the transcription activation domain) is a member of the p53 
family of transcription factors and is essential for epithelial maintenance and epidermal morphogenesis (Mills et al. 
1999; Yang et al. 1998). ΔNP63α is expressed in keratinocytes and acts as a critical proliferative factor (Senoo et al. 
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2007). With an induced proliferation, ΔNP63α is expected to be downregulated. The interstitial collagenase (also 
known as matrix metalloproteinase 1 or MMP-1) is responsible for maintaining the dermal extracellular matrix 
structure. The observed disorganization and degeneration of dermal extracellular matrix in UV exposed skin is due 
to an increased MMP-1 production (Lahmann et al. 2001; Scharffetter et al. 1991).  
Combined skin exposures to PAHs and UV-S and their impact on PAH absorption have until now not been well 
assessed. The in vitro flow-through diffusion cell system is suitable to study skin absorption ex vivo. The diffusion 
cell is separated into two chambers with a skin flap; the upper donor chamber (concentration of selected PAHs) and 
a lower receiver compartment with a continuous flow of liquid. The cumulative PAH concentrations in the receiver 
compartment is plotted over 24 hours; this permeation curve is used to calculate absorption rates across the skin. In 
this in vitro study, we characterized permeation of PAHs across human viable skin applied as a mixture and as BFC 
with and without simultaneous UV-S exposures. Our hypothesis was that in this experimental design, human skin 
permeation rates (J) and time until permeation across the skin barrier (Tlag) would be significantly different between 
skin exposed to PAHs alone and PAHs with simultaneous co-exposures to UV-S. We also explored possible skin 
biomarkers for UV exposures such as p53, ΔNP63α, cKIT, and MMP1. Understanding PAH skin absorption when 
co-exposure to UV-S is present can provide insight into internal PAH dose and consequently carcinogenic potential. 
The skin permeation parameters can be used to estimate the body burden in order to evaluate phototoxic responses 
based on PAH dose.  
 
Methods 
Chemicals Naphthalene (CAS no. 91-20-1), anthracene (CAS no.120-12-7), pyrene (CAS no. 129-00-0), chrysene 
(CAS no. 218-01-9), and benzo[a]pyrene (CAS no. 50-32-8) were purchased from Sigma Aldrich (Buchs, 
Switzerland). A standard mixture was made adding 5 mg/ml of each PAH in acetone, this is referred to as the “PAH 
mix”. Polyoxyethylene oleyl ether (Brij®-98, CAS no. 9004-98-2) was purchased from SigmaAldrich (Switzerland). 
Bitumen fume generation. The fume from obtained road construction bitumen (CAS 8052-42-4; CTW-
Strassenbaustoffe AG, Switzerland) was generated in a week long process. Information regarding the bitumen fume 
generator itself has been described previously (Sutter et al. 2016). Briefly, the bitumen was heated in a vessel to 170º 
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C, and fume collected in a condensation system, before extraction with dichloromethane. Dichloromethane was gently 
evaporated until the BFC weight reduction was stable. Seven days of continued generation gave 2-4 mL of BFC, 
which was diluted in toluene and shipped to the skin experiment laboratory.  
Solar light lamp. A 1000W xenon lamp (Solar LIGHT® Model LS-1000-4S-009 Solar Simulator, Glenside, 
Pennsylvania, USA) was used for the experiments. The UV-S spectrum comprised of 9.5% UVB and 90.5% UVA, 
closely matching the spectrum of natural sunlight (Diffey 2002). The standard erythemal dose (SED), which is 
equivalent to 100 J/m2, was measured with an erythema dose detector (Solar Light radiometer PMA2100 equipped 
with PMA2101S S/N: 17789).  Exposure times chosen for the experiments were either 10-15 minutes equal to 22.5-
30 mJ/cm2 (2-3 SED) and 40 minutes equal to 60 mJ/cm2 (6 SED). In other words, a 10 min exposure from this UV 
lamp could give a sunburn in a person with very sensitive skin. For the comparison with outdoor measurements, 
given that it is not linear over the day and that it is dependent on the weather, could be interpreted as exposure 
during sunbathing (horizontal to the ground) at noon in the summer for 1 hour (Milon et al. 2007). 
Human skin. Surgically removed skin from patients (N=10; where five donor skins were used for skin permeation 
studies and five for histological examination) undergoing abdominoplasty at the Lausanne university hospital 
(CHUV). Skin was obtained from the Department of Musculoskeletal Medicine (DAL) biobank, under anonymous 
donation, in accordance with its regulation and accepted by the cantonal ethics committee under protocol 264/12. No 
more than two hours elapsed from time of surgery-end to the skin was mounted onto the flow-through diffusion 
cells. No personal parameters regarding the patients were retained.  
Flow-through diffusion cell experiments. The skin was dermatomed (Acculan®II, B. Braun/Aesculap, Sempach, 
Switzerland) to a thickness of 800 µm, and the skin discs mounted onto the flow-through diffusion cells. A rack of 
six jacketed flow-through diffusion cells (receptor volume 12 mL; PermaGear bought from SES Analytical System, 
Bechenheim, Germany) was operated at 32°C. For the permeation studies, the peristaltic pump (Ismatec IPC-N, 
IDEX Health & Science GmbH, Wertheim-Mondfeld, Germany) ran at a flow rate of 40 µl/min, and a fraction 
collector (FC 204, Gilson Inc., Middleton, WI, USA) automatically sampled the reservoir liquid; saline solution with 
6% Brij®. For the skin biomarker studies, the system was operated in static mode. To keep the skin nourished 
throughout the 24h experiment, the reservoir liquid was Dulbecco’s Modified Eagle’s Medium (DMEM D6429 from 
Aldrich-Sigma, Switzerland). Skin was considered stabilized when the trans epidermal water loss (TEWL) 
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(VapoMeter wireless, Delfin Technologies Ltd., Kuopio, Finland) readings were stable and below 11 g/m2/h 
(Pinnagoda et al. 1990). If TEWL were above this value, the skin discs were deemed damaged and replaced. The 
exposed skin area was 1.77 cm2. A sample of the PAH mixture (60 µL) or BFC (60 µL) was added to the mounted 
skin and the UV-S exposure applied with a dose equivalent to six SED (60 mJ/cm2). This applied amount 
corresponds to infinite dose. The cells were run in duplicate or triplicate depending on amount of donor skin for 
each exposure (PAH with or without UV-S) and controls. The automated sampling collection was set for intervals 
lasting 24 hours. Samples were collected in brown glass vials as PAHs are sensitive to light. Our study complies 
with the OECD guideline 428 in: describing the skin origin, skin preparation, proof of skin integrity using the 
TEWL, temperature (32°C), the choice of a suitable receptor fluid, the description of the diffusion cells used, the 
actual area of skin dosed, the number of cells/samples and donors,  the duration of sampling period (24h). We did 
not include the determination of the PAH amount retained in skin after washing. 
Chemical analysis. PAH concentrations were determined for the bitumen condensate (Table 1) used in the 
experiments. The brown collection vials from the flow-through diffusion cell experiments were extracted before 
analysis. The extraction method has already been published (Huynh et al. 2007). Briefly, the solid phase extraction 
column (SPE; HyperSep C18, 500 mg, 6 ml) was conditioned (methanol (5 ml) and washed with water (5 ml)). The 
total sampled volume was added and washed twice with water (5 ml). The PAHs were eluded with ethyl acetate (5 
ml), dried, and reconstituted in acetonitrile (500 µl). Samples were injected into a high performance liquid 
chromatograph (HPLC) and analytically separated on a capillary column (Pinnacle II, PAH, 4 µm 150 x 3,2 mm) at 
30°C, 1.3 ml/min and with a mobile phase A (water:acetonitril 50:50) and B (100% acetonitril) with the following 
%A:%B gradient: 0 min 80:20, 3 min 80:20, 10 min 0:100, and 15 min 0:100. The analytes were detected and 
quantified by fluorescence (ProStar 363) with the following excitation (λex) and emission (λex) wavelengths (nm); 
naphthalene λex 280  λem 340, anthracene λex 250  λem 376, pyrene λex 333  λem 382, chrysene λex 280  λem 378, and 
benzo(a)pyrene λex 296  λem 405. The quantification limits were from 10-20 ng/mL for the five PAHs.  
Data analysis. Permeability coefficients (Kp) were estimated from the slopes of the cumulative absorption plots 
over time. Lag times (τ) were estimated as the intercept of the steady state portion of the permeability rate (J) curves 
with the time axis. Individual permeation rates were calculated from each diffusion cell and the mean and standard 
deviations were calculated for the group. Kp was estimated by dividing J with the applied concentration.  
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Gene expression biomarkers. The skin was irradiated with the lamp for 15-20 or 40 minutes which is equivalent to a 
sun exposure of 3-4 or 8 hrs in Switzerland. Several incubation times after exposure were tested: 0, 1h and 24 hrs. 
After an incubation period of 1 or 24 hrs, the skin sections were removed from the flow-through diffusion cells and 
cut to keep only the most central part of the skin. All skin samples were sent for routine pathological staining 
analyses. The paraffin-embedded and formalin-fixed skin were stained for immunohistochemistry using normal 
hematoxilin-eosin (H&E) staining; p53 expression with monoclonal mouse Anti-human P53 protein, clone DO-7 (as 
described in (Fonseca et al. 2016)); p63 expression with mouse monoclonal, clone DAK-p63, core DNA-binding 
domain of human p63 protein reacting with TAp63 and ΔNp63 isoforms of p63); cKit/CD117 expression with rabbit 
polyclonal.  
The histology slides were analyzed using a microscope (Nikon 90i) with an integrated camera. Each image was 
studied in 10x, 40x, and 100x resolution. Signs of irritation and cell damage were categorized on the hematoxyline 
eosin (HE) staining, in particular the accumulation of fluid between the keratinocytes in the epidermis (spongiosis) 
and vacuolization of the basal epidermal layer (epidermolysis) (Miles et al. 2014). The p53 grading was performed 
single-blinded by a dermato-pathology medical doctor. We defined the intensity of p53 in four quantitative stages 
(none, weak, middle, strong) and qualitatively by color (none, clear, brown, dark). The low quantitative stage was 
graded from five “hot spots” and therefore considered positive.  
MMP1gene expression. The skin discs were immediately flash-frozen (liquid nitrogen) after the experiment. To 
homogenize the tissue, the skin samples were first cut with a cryostat (25 micron sections) and placed in 
guanidinium thiocyanate-phenol-chloroform (1mL) (Trizol®, Life Technologies, Zug, Europe). Then, the skin 
sample was crushed with a series of syringes with decreasing needle diameter (19G, 20G, 25G) to completely 
disrupt the tissue. RNA was extracted from the homogenized sample using Trizol® (Life Technologies, Zug, 
Europe) following the manufacturer's protocol. RNA was re-suspended in RNAase-free water (50 µl). The extracted 
RNA (1 µg) was reverse transcribed into cDNA using the TaqMan kit trancription reverse reaction (Applied 
Biosystems) and hexamers (primers hazard) according to the manufacturer's protocol. Real time PCR analyses were 
performed using a StepOne ™ machine plus (Life Technologies, Zug, Europe). Relative gene expression was 
analyzed with the 2– ΔΔCT method and normalized to b-actin house keeping gene.. No adjustments were needed 
when certified specific MMP1 primers with a probe (MMP1 Hs00233958_m1, Actin Hs99999903_m) were used 
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(Life Technologies, Zug, Europe). Each reaction contained 50 ng cDNA (20 µl), primer (1 µl) and TaqMan 
Universal Master Mix II (10 µl)(Life Tecnologies, Zug, Europe). We followed the standard amplification program; 
20 seconds at 95 degrees, followed by 40 cycles of 1 second at 95 degrees and 20 seconds at 60 degrees.  
Results 
Human skin permeation. The skin permeation curves for the five PAHs after application of the PAH mixture and 
bitumen condensate with and without co-exposures to UV-S are shown in figure 1A and B. The skin permeation 
parameters are given in Table 1. The PAHs in the PAH mixture had low permeation rates (J) (0.97-13.01 ng/cm2/h), 
disparate lag times (Tlag) (1-10h), and from moderate to slow permeation coefficient (Kp). With co-exposures to 
UV-S, the PAHs still had low Js (0.40-6.35 ng/cm2/h); although the Js for the individual PAHs changed when co-
exposed to UV-S; while Tlag remained unchanged and disparate (1-11h). 
When the applied PAH mixture had co-exposure to UV-S, two PAHs behaved similarly with respect to simultaneous 
exposure to UV-S; naphthalene, and BaP, and their Js were halved (Table 1). Tlag increased by one hour for both. 
The opposite J pattern was observed for anthracene, pyrene, and chrysene where Js increased 27%, 43%, and 44%, 
respectively. The Tlag were similar as without co-exposure to UV-S (Table 1). 
The PAHs in BFC had low Js (0.01-1.08 ng/cm2/h), disparate lag times (1-13.5h), and from moderate to slow Kp 
values. Chrysene was not detected in the reservoir liquid. With co-exposures to UV-S, the PAHs still had low Js 
(0.01-1.08 ng/cm2/h) although the Js for the individual PAHs changed when co-exposed to UV-S.  
When the applied BFC had co-exposure to UV-S, the Js for naphthalene, anthracene, and pyrene increased 
compared to BFC applied without UV-S (Table 1). Large increases in Js were observed for naphthalene (300%), 
anthracene (600%) and pyrene (doubled). Tlag decreased for naphthalene (60%), anthracene (150%) and BaP 
(460%). The Tlag remained unchanged for pyrene (Table 1). 
Skin biomarkers. Histopathology results from skin discs stained with HE showed no signs of irritation for the 
controls (undergone the same experimental treatment except for exposure). Skin exposed to UV-S for 15 minutes 
showed less irritation compared to skin with 40 minutes and some irritation was observed in skin exposed to the 
PAH mixture. Co-exposure to PAH mixture and UV-S showed appreciable amount of irritation. Some expression of 
p53 was observed with co-exposures to UV-S and PAHs but not with exposure to PAHs alone. The p53 expression 
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increased with increasing UV-S exposures (15-20 and 40 minutes) (figure 3).  This increase was only seen if the skin 
was kept in the flow-through diffusion cells with cell culture media for 24 hours but not in saline (data not shown). 
We did not observe the expected up-regulation of cKIT/CD117. The choice to determine MMP-1 expression after 24 
h was made based on prior experience with skin cell cultures and in vivo experiments (Gebbers et al. 2007; Liardet 
et al. 2001). However, no conclusion can be made regarding the expression of MMP-1 gene because we could not 
isolate sufficient RNA from the human skin, even after treating the skin with RNAase immediately after obtaining it.  
 
Discussion 
Simultaneous exposures to PAHs and UV-S increased skin permeation for all PAHs except for chrysene in BFC, 
and naphthalene and BaP in the PAH mixture. This increase in skin permeation when co-exposed to UV has been 
shown for caffeine, which increased 338% after the skin was irradiated with UVB doses above 420 mJ/cm2 in a 
flow-through diffusion cell system in vitro (Gelis et al. 2002). The authors report that the skin integrity assessed by 
TEWL measurements was greatly different before and after UV-S exposure at this irradiation level. Below this UV 
dose, no difference in TEWL measurements before and after exposure was observed. This suggests that the stratum 
corneum was not damaged from UV-S exposure below this threshold. We cannot relate our observed differences in 
PAH skin permeation rates to stratum corneum damage because our experimental set-up reflected daily outdoor 
exposure scenarios which were far smaller than the caffeine study, with up to 60 mJ/cm2, and the TEWL 
measurements did not change before and after experiments.  
UV-S exposure decrease the intercellular strength, strain, and cell cohesion thus increasing the biomechanical 
driving force for damage while simultaneously decreasing the skin’s natural ability to resist, compromising the 
critical barrier function of the skin (Biniek, Levi, and Dauskardt 2012). This could be a plausible explanation for the 
increase in PAH permeation we observed in our experiments, and if so, then a possible decrease in intercellular 
strength cannot be measured by TEWL. Indeed, cellular damages have been observed below the reported 420 
mJ/cm2 UV-S threshold in other studies. Keratinocytes exposed in vitro to UVA and UVB, separately, showed 
reduced plasma membrane stability, reduced proliferation and increased apoptosis compared to controls (sham-
treated cells)(Larsson et al. 2005).  
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UVA irradiation induced loss of glutathione (GSH) in keratinocytes in vitro (Larsson et al. 2005). In phase I of the 
biotransformation, PAH epoxides are generated to convert nonpolar PAHs to polar PAHs and conjugated with 
glutathione in phase II of the biotransformation to facilitate excretion. Skin transplants have shown to have 
significant capacity for phase II metabolism including GSH conjugation (Manevski et al. 2015). However, if phase 
II biotransformation capacity is reduced (e.g. loss of GSH), these epoxides are converted into phenols and diols. 
Before these hydroxylated derivatives are conjugated and excreted, they may undergo a number of oxidation and 
hydroxylation reactions, converting the phenols to phenol-epoxides and subsequently to diphenols and triols, diols to 
tetrols and diol-epoxides, and triols to triol-epoxides and pentols as reviewed in (IARC 2010). These metabolites 
were not measured therefore we cannot rule out a possible underestimation of PAH skin absorption in our 
experiments. 
PAHs absorb UV light resulting in the formation of different types of photoreaction products and lower molecular 
weight photodegradation products (Yu 2002). This can occur via several different photochemical reactions; 
oxidation to oxygenated PAHs and PAH quinones; and reaction with NO2 or NO3 radicals in the atmosphere to form 
nitro-PAHs (reviewed in (Fu et al. 2012). The photooxidation of the parent PAHs, such as naphthalene, anthracene, 
pyrene, and BaP, produces hydroxylated products, PAH quinones, and ring opening products (reviewed in (Fu et al. 
2012)). Predicting photodegradation products is difficult due to the ring arrangements as photochemical reactions of 
PAHs are highly regioselective. In general, PAHs with a higher number of benzo-fused rings exhibit greater 
phototoxicity (Cerniglia 1992). This phototoxicity induces lipid peroxidation in a dose-dependent manner (Botta et 
al. 2009). A study of UV-induced cytotoxicity for 16 PAHs (US EPA priority list) in human skin HaCaT 
keratinocytes showed that all, except naphthalene, exhibited phototoxicity to some extent (Wang et al. 2007). We 
did not reach a statistical difference between the experiments with or without UV co-exposures, as the variability 
introduced in experiments with UV exposure was extremely large, as can be observed from the error bars in the 
permeation figures. This could possibly be explained by the variable photooxidation products or the amount of 
phototoxicity produced, or again, that we did not measure all possible metabolites. Another explanation could be the 
influence of temperature on Kp. Modeled Kp values have shown that an increase in four degrees Celsius can double 
the Kp value (Norman et al. 2008), while experimental Kp values had a 1-28% difference when the temperature 
ranged from 30 to 40°C (Corley et al 2000). Thus, even small changes in temperature can increase the variability. 
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BaP with co-exposure to UVA have shown to produce both DNA strand breaks and oxidative lesions in human 
keratinocytes in vitro while each agent alone did not induce detectable effects (Crallan, Ingham, and Routledge 
2005). The authors suggested that the ultimate BaP carcinogen - BaP diol epoxide – forms an adduct that is 
photosensitive and the subsequent exposure to UVA leads to DNA strand breakages; or alternatively, BaP, a 
photomutagenic substance itself absorbing energy in the UVA range, can become activated by UVA light and 
subsequently cause damage. In either of the two proposed mechanisms, BaP co-exposed to UVA irradiation would 
react inside the skin, thus not be detected in the reservoir liquid in the flow-through diffusion cells. Therefore, it 
would be false to conclude that the skin absoption was lower for BaP in the PAH mixture co-exposed with UV-S 
than without. This reversed pattern was not observed for BaP in BFC where BaP permeated skin to a greater extent 
when co-exposed to UV-S compared to without depicting the same pattern as for the other PAHs in BFC. BFC 
contains not only the phototoxic PAHs, but also the phototoxic nitro and sulfur heterocycle constituents. The 
increase in phototoxicity could potentially lead to a corresponding increase in the damage of the critical barrier 
function of the skin while also more of the BaP parent compounds as less photoreactive products are generated. 
Naphthalene and BaP showed the same skin permeation patterns; greater permeation with UV-S exposure compared 
without when applied in BFC but the opposite when applied as a PAH mixture. There exist several plausible 
explanations for this observation; (1) Naphthalene applied as a PAH mixture evaporates faster than it is absorbed 
into the skin. The diffusion cell system is kept at 32°C and is equipped with jacketed cells to maintain this 
temperature. The solar lamp did not increase the skin surface temperature by more than 2°C; however, given 
naphthalene’s low partial pressure (0.013 kPa at 299°K) this set-up could potentially be sufficient to evaporate the 
applied naphthalene from the skin. This explanation would not hold for naphthalene in BFC; (2) Naphthalene 
rapidly undergoes radical reactions with UV-S producing quinines that we did not measure; and /or (3) BFC exhibit 
a vehicle effect on naphthalene increasing the absorption across the SC. In a study of naphthalene skin absorption 
from jet fuel, naphthalene was quickly absorbed through the epidermis when applied to the skin in jet fuel which 
contains naphta and other additives (Kim, Andersen, and Nylander-French 2006). PAH mixture in acetone as 
according to OECD 420 guideline does not mimic BFC in the laboratory and consequently, a possible vehicle effect 
would not have been taken into account.   
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Biomarker assessment. Never frozen, dermatomed skin flaps maintained in culture on diffusion cells have been 
shown to maintain their viability for at least 24 hours (Gelis et al. 2002). The UV-S doses (none, 22.5-30, and 60 
mJ/cm2) presently used resulted in a dose-dependent tissue irritation as assessed according to the method of Miles et 
al 2014 (Miles et al. 2014). This shows the usefulness of this in vitro skin irritation assessment method using human 
viable skin and histopathology. The up-regulation of p53 increased in a dose-dependent manner with UV-S (figure 
1) as have been reported previously (Latonen, Taya, and Laiho 2001). Although qualitatively assessed, the p53 up-
regulation was somewhat greater after co-exposure to PAH mixture and UV-S than UV-S alone. The p53 gene 
functions are indicators of the genome integrity, and are activated mainly when DNA is damaged. It acts as a 
transcription factor that regulates several genes (cell cycle control, cell apoptosis, cell signaling, extracellular matrix 
control, and cell structure). This p53 up-regulation has been reported; however, in skin biopsies from workers 
chronically exposed to bitumen fumes (Loreto et al. 2007). This is contrary to what we observed in our study; we 
did not observe an up-regulation of p53 when skin was exposed to PAH (as a mixture or in BFC) without co-
exposure to UV-S. The reason for the lack of p53 up-regulation in our in vitro experiment could be explained by a 
onetime exposure compared to chronic exposures. Or, the bitumen fume workers (Loreto et al. 2007) were paving 
roads outside thus having co-exposures to UV-S. The authors did not, however, measure UV exposure. As with the 
p53, we did not observe the expected down-regulation of p63. This gene, which is a p53-like gene, was found to be 
dramatically reduced in UV exposed keratinocytes (Liefer et al. 2000). One explanation could be the choice of 
antibody we used which was generated with the core DNA-binding domain that is present in all p63 isoforms thus 
not specific to ΔNp63a. We did not observe the expected up-regulation of cKIT/CD117 as previously seen in 
cultured human melanocytes exposed twice with a 48 h interval to UVB irradiation (0-80 mJ/cm2) (Hachiya et al. 
2001). This up-regulation of c-KIT was measured with RT-PCR. The cKIT staining method might be sufficiently 
sensitive for cell cultures but not sufficiently sensitive for skin discs since most of the cells in the skin sample are 
keratinocytes, not melanocytes where the cKIT receptors reside. The increase in cKIT receptors from UVB 
stimulation might take longer than the 24 hours we ran our experiments. Another possible explanation could be that 
the UV-S dose used caused sufficient keratinocyte cell death (as observed as skin irritation) thereby not stimulate 
SCF production and ultimately no cKIT induction.      
Selection of PAHs in mixture. Based on a previous study of bitumen fume exposure among road paving workers 
(Burstyn et al. 2002), we choose a mixture of five PAHs: naphthalene, anthracene, pyrene, chrysene, and BaP to 
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simulate bitumen fume exposure. Individual PAHs in bitumen fume (particulate phase) and vapor (gas phase) 
emitted during road paving and asphalt mixing (Burstyn et al. 2002) were quantified (mean values (standard error)) 
for fumes: 0.68 (0.32) µg/m3 naphthalene, 0.18 (0.05) µg/m3 anthracene, 0.17 (0.08) µg/m3 pyrene, 0.09 (0.02) 
µg/m3 chrysene, and 0.02 (0.01) µg/m3 BaP; and for vapor phase: 4.65 (0.50) µg/m3 naphthalene, 1.24 (0.20) µg/m3 
anthracene, 0.39 (0.04) µg/m3 pyrene, 0.02 (0.003) µg/m3 chrysene, and 0.02 (0.01) µg/m3 BaP. The concentrations 
of individual PAHs in the mixture we used were a result from several tries with lower initial PAH concentrations 
which were below the limit of detection, making it difficult to construct permeation curves. The BFC we generated 
(Sutter et al. 2016) and applied to the skin, contained somewhat different individual PAH concentration ratios 
compared to the personal samples reported in the literature. Our BFC had lower amounts of pyrene and anthracene 
than measured among pavers, and this could be due to the loss of the vapor phase in our sample. The BaP 
concentration in our BFC was greater than previously reported in two studies (Roy, Kriech, and Mackerer 2007; 
Reinke et al. 2000); however, these studies measured bitumen fume emissions from storage tanks and do not reflect 
workplace exposures directly. We believe our experiments simulated well PAH exposures because the BFC sample 
was generated from bitumen obtained directly from a company paving roads in Switzerland.  
PAH mixture vs BFC. Simulating bitumen exposure in the laboratory by mixing the individual PAHs normally found 
in bitumen did not give the same skin permeation results as the PAHs in BFC. Bitumen is the residue resulting from 
vacuum distillation of selected petroleum crude oils and contains many other substances such as aliphatic 
compounds, cyclic alkanes, aromatic hydrocarbons, heterocyclic compounds containing nitrogen, oxygen and sulfur 
atoms, and metals in addition to PAHs. Other organic molecules in the BFC might increase the permeation of PAHs 
through human skin which could explain the PAHs’ much shorter timelags in BFC compared to the mixture.  
Possible radical reaction products that could under estimate the total amount of PAHs absorbed remain a limitation 
in our study; however, we were successful in showing that the absorption of PAHs do increase with simultaneous 
UV-S exposures. 
In conclusion, our study provides robust human skin PAH absorption estimates based on several skin donors and 
replicates. Although the differences between PAH exposures with co-exposures to UV or without, did not reach 
statistical significance, the five PAHs in the mixture were shown to have low permeation rates (0.97-13.01 
ng/cm2/h) and disparate lag times (1-10h). With co-exposures to UV-S, the PAHs’ permeation rates remained low, 
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but the permeation rates increased for anthracene, pyrene and chrysene. For the PAHs in bitumen fume condensate, 
the permeation rates for naphthalene, anthracene, and pyrene increased with co-exposure to UVS. The vehicle 
matrix could potentially be the reason for this discrepancy between the PAH mixture and BFC as the latter contains 
additional not identified substances. We suggest using the skin flaps from permeation experiments to assess skin 
irritation (H&E staining) and p53 up-regulation, and continue to explore other skin biomarkers in this in vitro 
experimental set-up. To reduce the carcinogenic risks among workers exposed to PAHs and UV-S simultaneously it 
is recommended to increase hygienic measures such as cleaning tools and frequent hand washing to reduce skin 
PAH exposures, and simultaneously increase time spent in the shade (use of awnings for break times for example) 
and use protective clothing against sun exposures. 
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 Figure 1 A Skin permeation curves and standard deviations for naphthalene and BaP in BFC (left column) and PAH mixture 
(right column) displaying hours of exposure (x-axis) by cumulative amount per skin area (ng/cm2) (y-axis).  
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Figure 1 B Skin permeation curves and standard deviation for anthracene, pyrene, and chrysene in BFC (left column) and PAH 
mixture (right column) displaying hours of exposure (x-axis) by cumulative amount per skin area (ng/cm2) (y-axis).  
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 Control UV exposed (40 min) 
P53 
  
P63 
  
Figure 2 Examples of skin histology results; p53 (magnification 100x) and p63 (magnification 40x). Brown staining indicates 
presence of the antibody. A difference in p53 expression was only visible after 40 min of UV-S exposure and after 24 hrs of 
incubation in Dulbecco’s Modified Eagle’s Medium at 32°C.  
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Figure 3 Expression of p53 increases with increasing UV exposure. Number of positive cells per fields identified as a measure 
of p53 upregulation (y-axis) and UV-S exposure times (x-axis) from four experiments (N=4 donors) in cell culture medium 
after 24 hours for control (no UV-S exposure) and exposed; 10-15 minutes equal to 22.5-30 mJ/cm2 and 40 minutes equal to 
60 mJ/cm2. The error bars indicate standard deviations 
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Table 1 Concentrations of individual PAHs in the bitumen condensate and the PAH mixture applied to the skin (60 µl) and the resulting permeation rates (J), time lag (Tlag), 
and coefficient (Kp)  
    PAH mixture     Bitumen Fume Condensate 
PAH   Start conc   J mean (SD) Tlag  Kp     Start conc   J mean (SD)   Tlag Kp 
  n (ng/µl) (ng/cm2/h) (h) (cm/h)   n (ng/µl) (ng/cm2/h) (h) (cm/h) 
Naphthalene 6 5000 13.01 (15.25) 5 2.60E-03 
 
4 260 0.26 (0.29) 13.5 1.00E-03 
Naphthalene + UV-S 12 5000 6.35 (5.43) 6 1.27E-03 
 
8 260 1.08 (2.23) 8.5 4.15E-03 
              
Anthracene 6 5000 1.73 (0.92) 5 3.46E-04 
 
4 50 0.02 (0.02) 5 4.00E-04 
Anthracene + UV-S 12 5000 2.20 (1.44) 5 4.40E-04 
 
8 50 0.12 (0.18) 2 2.40E-03 
              
Pyrene 6 5000 2.77 (2.40) 10 5.54E-04 
 
4 50 0.04 (0.08) 1 8.00E-04 
Pyrene + UV-S 12 5000 3.98 (3.37) 11 7.96E-04 
 
8 50 0.08 (0.09) 1 1.60E-03               
Chrysene 2 5000 1.46 (1.44) 1 2.92E-04 
 
4 90 NA NA NA 
 
Chrysene + UV-S 4 5000 2.11 (1.44) 1 4.22E-04 
 
8 90 NA NA NA 
 
              
BaP 6 5000 0.97 (2.09) 1 1.94E-04 
 
4 60 0.01 (0.01) 7 1.67E-04 
BaP + UV-S 12 5000 0.40 (0.66) 1.5 8.00E-05   8 60 0.01 (0.02) 1.5 1.67E-04 
NA Not Available – no chrysene was detected in the reservoir fluid 
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